138 related articles for article (PubMed ID: 6323189)
21. Effect of 3'-amino-3'-deoxythymidine on L1210 and P388 leukemias in mice.
Lin TS; Fischer PH; Prusoff WH
Biochem Pharmacol; 1982 Jan; 31(1):125-8. PubMed ID: 7059345
[No Abstract] [Full Text] [Related]
22. A new steroidal alkylating agent with improved activity in advanced murine leukemias.
Catsoulacos P; Politis D; Wampler GL
Cancer Chemother Pharmacol; 1979; 3(1):67-70. PubMed ID: 535128
[TBL] [Abstract][Full Text] [Related]
23. [Experimental combination chemotherapy of YNK01, a novel analog of cytarabine, with other antitumor agents].
Uchida T; Nagahata T; Arakawa M; Ekimoto H; Takahashi K
Gan To Kagaku Ryoho; 1990 Jul; 17(7):1351-6. PubMed ID: 2114829
[TBL] [Abstract][Full Text] [Related]
24. Antitumor activity of the 3'-chloroethylnitrosourea analog of thymidine and the prevention by co-administered thymidine of lethality but not of anticancer activity.
Lin TS; Fischer PH; Marsh JC; Prusoff WH
Cancer Res; 1982 May; 42(5):1624-9. PubMed ID: 7066884
[TBL] [Abstract][Full Text] [Related]
25. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
[TBL] [Abstract][Full Text] [Related]
26. Effect of (E)-5-(2-bromovinyl)uracil on the catabolism and antitumor activity of 5-fluorouracil in rats and leukemic mice.
Desgranges C; Razaka G; De Clercq E; Herdewijn P; Balzarini J; Drouillet F; Bricaud H
Cancer Res; 1986 Mar; 46(3):1094-101. PubMed ID: 3943086
[TBL] [Abstract][Full Text] [Related]
27. Effect of concurrent calcium leucovorin infusion on 5-fluorouracil cytotoxicity against murine L1210 leukemia.
Klubes P; Cerna I; Meldon MA
Cancer Chemother Pharmacol; 1981; 6(2):121-5. PubMed ID: 6975667
[TBL] [Abstract][Full Text] [Related]
28. Effect of thymidine on the toxicity and antitumor activity of ftorafur.
Grossie VB; Loo TL
Cancer Treat Rep; 1981; 65(11-12):1087-91. PubMed ID: 6794908
[TBL] [Abstract][Full Text] [Related]
29. Antitumor activity of spergualin, a novel antitumor antibiotic.
Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Oct; 39(10):1461-6. PubMed ID: 3781914
[TBL] [Abstract][Full Text] [Related]
30. In vivo antitumor activity of 6-benzyl-1,3-benzodioxole derivatives against the P388, L1210, B16, and M5076 murine models.
Jurd L; Narayanan VL; Paull KD
J Med Chem; 1987 Oct; 30(10):1752-6. PubMed ID: 2821258
[TBL] [Abstract][Full Text] [Related]
31. Activity of the anthracycline agent, 7-con-O-methylnogarol (7-OMEN), administered orally to mice bearing P388 or L1210 leukemia.
McGovren JP
Cancer Treat Rep; 1980; 64(4-5):727-9. PubMed ID: 6448690
[TBL] [Abstract][Full Text] [Related]
32. Overadditive synergism between the intercalators mitoxantrone and lucanthone in advanced L 12010 and P 388 leukemia.
Osswald H; Youssef M
J Cancer Res Clin Oncol; 1986; 111(2):137-40. PubMed ID: 2939092
[TBL] [Abstract][Full Text] [Related]
33. Tumor inhibition by metallocenes: activity against leukemias and detection of the systemic effect.
Köpf-Maier P; Wagner W; Hesse B; Köpf H
Eur J Cancer (1965); 1981 Jun; 17(6):665-9. PubMed ID: 7308264
[No Abstract] [Full Text] [Related]
34. Metoclopramide and nitrendipine are unable to enhance cytotoxicity of mitoxantrone in sensitive and resistant murine leukemias in vivo.
Potemski P; Polakowski P
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):249-53. PubMed ID: 9597095
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic synergy of trimetrexate (CI-898) in combination with doxorubicin, vincristine, cytoxan, 6-thioguanine, cisplatin, or 5-fluorouracil against intraperitoneally implanted P388 leukemia.
Leopold WR; Dykes DJ; Griswold DP
NCI Monogr; 1987; (5):99-104. PubMed ID: 2963231
[TBL] [Abstract][Full Text] [Related]
36. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
[TBL] [Abstract][Full Text] [Related]
37. In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in mice.
Santelli G; Valeriote F
J Natl Cancer Inst; 1978 Sep; 61(3):843-7. PubMed ID: 278862
[TBL] [Abstract][Full Text] [Related]
38. Effect of pyrimidines, purines and their nucleosides on antitumor activity of 5-fluorouracil against L-1210 leukemia.
Iigo M; Ando N; Hoshi A; Kuretani K
J Pharmacobiodyn; 1982 Jul; 5(7):515-20. PubMed ID: 7131236
[TBL] [Abstract][Full Text] [Related]
39. Therapy of P388 leukemia with benzaldehyde.
Balázová E; Koza I
Neoplasma; 1988; 35(6):725-8. PubMed ID: 3221939
[TBL] [Abstract][Full Text] [Related]
40. Elevation of plasma levels of fluorinated pyrimidines by guanosine 5'-monophosphate.
Iigo M; Yamaizumi Z; Nishimura S; Hoshi A
Cancer Chemother Pharmacol; 1987; 20(1):1-4. PubMed ID: 3040286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
